logo
Plus   Neg
Share
Email

China Pharma Posts Wider Loss In FY19 - Quick Facts

China Pharma Holdings, Inc. (CPHI) reported a full year 2019 loss per common share of $0.48 compared to a loss of $0.25, previous year. Gross margin was 13.6% compared to 16.0%. Gross profit was $1.5 million, compared to $2.0 million, previous year.

Full year 2019 revenue decreased 11.4% to $11.0 million from $12.3 million, prior year. The company said this decrease in sales revenue was mainly due to the increased standards of drug tender procurement of GPO and the decreased "drug ratio".

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
RELATED NEWS
Follow RTT